Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A Phase I/II Pilot Trial
Paola Queirolo, Marco Ponte, Marco Gipponi, Ferdinando Cafiero, Alberto Peressini, Claudia Semino, Gabriella Pietra, Rita Lionetto, Stefania Vecchio, Iole Ribizzi, Giovanni Melioli, Mario R. Sertoli,Volume:
6
Language:
english
Pages:
7
DOI:
10.1007/s10434-999-0272-4
Date:
April, 1999
File:
PDF, 51 KB
english, 1999